As of 2024-12-12, the Fair Value of Kinarus Therapeutics Holding AG (KNRS.SW) is -122.81 CHF. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 14.80 CHF, the upside of Kinarus Therapeutics Holding AG is -929.82%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -0.94 | -0.01 | -0.14 | -40.58 | -13.91 | -11.12 |
| YoY growth | -23.36% | 99.26% | -1,942.86% | -28,279.02% | 65.74% | -6,016.05% |
| Market Cap (mil) | 6.80 |
| P/E | |
| Forward P/E |
| EPS | -24.56 |
| Avg earnings growth rate | -6,016.05% |
| TTM earnings | -13.91 |